Document is current
Any future updates will be listed below
-
Authors
Coon, Michael E.
Stephan, Sirkka B.
Gupta, Vikas
Kealey, Colin P.
Stephan, Matthias T. https://orcid.org/0000-0001-8310-0100
-
Funding
Funding for this research was provided by:
Bezos Family Foundation
- License Information
-
More Information
Article History
Received: 15 October 2018
Accepted: 7 November 2019
First Online: 9 December 2019
Competing interests
: The Fred Hutchinson Cancer Center and M.T.S. have filed a patent pertaining to TFN-based micromeshes and stents for the delivery of tumour-specific T cells (PCT/US2017/067965), which was licensed by Monarch Biosciences. The other authors declare no competing interests.
